Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 -12.72 -0.08%
S&P 500 1,875.39 -4.16 -0.22%
NASDAQ 4,126.97 -34.49 -0.83%
Ticker Volume Price Price Delta
STOXX 50 3,175.97 -23.72 -0.74%
FTSE 100 6,674.74 -7.02 -0.11%
DAX 9,544.19 -55.90 -0.58%
Ticker Volume Price Price Delta
NIKKEI 14,528.66 -17.61 -0.12%
TOPIX 1,172.19 -1.62 -0.14%
HANG SENG 22,509.64 -221.04 -0.97%

Free Research Report on Pike Electric Corp., DARA Biosciences, Inc., Deutsche Bank Niamen AKT, Delcath Systems, Inc. and Dollar



Free Research Report on Pike Electric Corp., DARA Biosciences, Inc., Deutsche
       Bank Niamen AKT, Delcath Systems, Inc. and Dollar General Corp.

PR Newswire

NEW YORK, January 31, 2013

NEW YORK, January 31, 2013 /PRNewswire/ --

Today, Traders Insight announced new research reports highlighting Pike
Electric Corp. (NYSE: PIKE), DARA Biosciences, Inc. (Nasdaq: DARA), Deutsche
Bank Niamen AKT (NYSE: DB), Delcath Systems, Inc. (Nasdaq: DCTH) and Dollar
General Corp. (NYSE: DG). Today's readers may access these reports free of
charge - including full price targets, industry analysis and analyst ratings -
via the links below.

Pike Electric Corp. Research Report
Pike Electric Corporation (Pike), provides energy solutions for
investor-owned, municipal and co-operative utilities in the United States. The
Company's services include siting, permitting, engineering, design,
installation, maintenance and repair of power delivery systems, including
renewable energy projects. The Company's service offering include planning and
siting, engineering and design, , maintenance and repair of power delivery
systems, including renewable energy projects. The Full Research Report on Pike
Electric Corp. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/7a03_PIKE]

DARA Biosciences, Inc. Research Report
DARA BioSciences, Inc. is a specialty pharmaceutical company focused on the
development and commercialization of oncology treatment and supportive care
pharmaceutical products. The Company has the exclusive United States marketing
rights to its Soltamox (oral liquid tamoxifen). The Full Research Report on
DARA Biosciences, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/d1ab_DARA]

Deutsche Bank Niamen AKT Research Report
Deutsche Bank AG is a Germany-based global investment bank. The Company
diversifies its activities into three group divisions: Corporate & Investment
Bank (CIB); Private Clients and Asset Management (PCAM), and Corporate
Investments (CI). The Full Research Report on Deutsche Bank Niamen AKT -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/47a5_DB]

Delcath Systems, Inc. Research Report
Delcath Systems, Inc. (Delcath) is a development-stage, specialty
pharmaceutical and medical device company, focused on oncology, initially
cancers in the liver. Delcath focuses on the development and clinical study of
the Delcath chemosaturation system. The Delcath chemosaturation system allows
the administration of concentrated regional chemotherapy by isolating the
circulatory system of the targeted organ. The Full Research Report on Delcath
Systems, Inc. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/2263_DCTH]

Dollar General Corp. Research Report
Dollar General Corporation is a discount retailer in the United States by
number of stores, with 9,961 stores located in 39 states as of March 2, 2012,
primarily in the southern, southwestern, midwestern and eastern United States.
The Company offers a selection of merchandise, including consumables,
seasonal, home products and apparel. The Full Research Report on Dollar
General Corp. - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.TradersInsight.net/r/2013-01-30/9a7f_DG]

About Traders Insight
Our model of enabling open collaboration between members is breaking new
ground into the investment community. By tapping into the resources of the
community, we are crowd-sourcing our reach. As a result -- we have been able
to identify some of the greatest moving companies on the market today. The
evidence is in the results, join today and experience what you've been
missing.

Press Contact:

Cora S. Patton
press@TradersInsight.net
+1-203-297-6092

SOURCE Traders Insight
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement